Pediatric Adverse Event Analysis By FDA Will Project Incidence Rates
Executive Summary
FDA plans to use hospital use data to project use among the in-patient pediatric population to determine incidence rates for adverse event reports mandated by the Best Pharmaceuticals for Children Act